The Arab Drug Company (EGX:ADCI)
Egypt flag Egypt · Delayed Price · Currency is EGP
178.05
-1.45 (-0.81%)
At close: Apr 23, 2026

The Arab Drug Company Ratios and Metrics

Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
2,1371,209482401275397
Market Cap Growth
137.48%150.60%20.27%45.83%-30.70%12.18%
Enterprise Value
2,5991,638766505302355
Last Close Price
178.0597.3636.0527.9317.4222.93
PE Ratio
9.476.085.465.643.613.91
Forward PE
-8.588.588.588.588.58
PS Ratio
1.731.080.610.630.550.74
PB Ratio
3.411.951.051.050.811.28
P/TBV Ratio
3.411.951.051.050.811.28
P/FCF Ratio
23.71--16.49-51.48
P/OCF Ratio
9.577.363.554.588.3710.85
EV/Sales Ratio
2.111.470.980.800.600.66
EV/EBITDA Ratio
0.100.066.355.083.012.73
EV/EBIT Ratio
7.105.256.485.213.322.90
EV/FCF Ratio
28.83--20.77-46.03
Debt / Equity Ratio
0.880.831.130.500.440.07
Debt / EBITDA Ratio
0.020.024.261.911.510.16
Debt / FCF Ratio
6.12--7.90-2.75
Net Debt / Equity Ratio
0.740.700.620.370.33-0.13
Net Debt / EBITDA Ratio
0.020.022.361.421.11-0.30
Net Debt / FCF Ratio
5.13-12.50-1.895.82-1.94-5.07
Asset Turnover
0.930.910.871.010.991.31
Inventory Turnover
2.452.312.121.711.611.85
Quick Ratio
0.480.631.010.730.680.80
Current Ratio
1.311.521.932.492.312.75
Return on Equity (ROE)
45.48%42.26%24.43%22.88%23.48%36.32%
Return on Assets (ROA)
17.27%15.87%8.13%9.66%11.12%18.67%
Return on Invested Capital (ROIC)
27.48%26.85%14.45%15.43%19.53%41.14%
Return on Capital Employed (ROCE)
42.60%36.00%15.00%19.80%23.10%39.50%
Earnings Yield
10.55%18.85%21.32%20.64%27.74%25.55%
FCF Yield
4.22%-2.86%-31.14%6.07%-20.74%1.94%
Dividend Yield
2.34%4.28%11.58%8.06%13.78%10.90%
Payout Ratio
32.19%27.70%35.11%45.29%57.06%38.31%
Buyback Yield / Dilution
---11.45%2.11%6.76%
Total Shareholder Return
2.34%4.28%11.58%19.51%15.89%17.66%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.